The largest database of trusted experimental protocols

3 protocols using perifosine

1

Anti-EphB6 Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-EphB6 was obtained from Santa Cruz (Dallas, TX, USA). Anti-phospho-Akt (Ser473), anti-phospho-S6K, anti-phospho-ERK1/2, and anti-GAPDH were purchased from Cell Signaling Technology (New England Biolabs Ltd., Whitby, ON, Canada). Anti-PARP was purchased from EMD Millipore (Billerica, Mass, USA). Anti-β-tubulin was obtained from Santa Cruz Biotechnology (Dallas, TX, USA). Bovine serum albumin (BSA) was purchased from BioShop Canada Inc. (Burlington, ON, Canada). Doxorubicin was purchased from Tocris Bioscience (Bristol, UK). Puromycin and polybrene were bought from Sigma-Aldrich (Oakville, ON, Canada). Resazurin was purchased from R&D Systems (Minneapolis, MN, USA). Perifosine was from Invivogen (San Diego, CA, USA). Tween-20 was from Fisher Scientific (Ottawa, ON, Canada).
+ Open protocol
+ Expand
2

Antibody Blocking and Signaling Inhibition in MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For antibody blocking experiments, MSCs were treated with 8 μg/ml purified anti‐mouse IL‐1β antibody or 8 μg/ml purified anti‐mouse IL‐6 antibody (BioLegend, San Diego, CA) in serum‐free medium for 2 hr and then stimulated with 50 ng/ml IL‐17. IgG (BioLegend) was used in the control group under the same conditions.
To study signaling inhibition, when MSCs reached subconfluence, MSCs were treated with 10 μM of the AKT inhibitor Perifosine, the JAK1 and JAK2 inhibitor AZD1480 (which is used to inhibit STAT3 signaling), or the MEK1/2 inhibitor U0126 (all obtained from InvivoGen, San Diego, CA), all solubilized in 0.1% dimethylsulfoxide (DMSO), in serum‐free medium for 2 hr, and then stimulated with 50 ng/ml IL‐17. DMSO alone was used in the control group under the same conditions.
+ Open protocol
+ Expand
3

Synergistic Anti-Leukemia Effects of Doxorubicin and Perifosine

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-ALL cells were treated with a solvent control or with increasing concentrations of doxorubicin alone, or in combination with a suboptimal concentration of perifosine (Invivogen) for 24 hours. Cell survival was monitored by resazurin staining. To assess synergistic effects, the CompuSyn software was used to generate combination indices for each drug combination, as previously described37 (link). Indices below 0.9 indicate synergism37 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!